Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-(4-Nitrophenyl)phthalimide, with the molecular formula C14H8N2O4, is a yellow crystalline powder that serves as a versatile intermediate in the chemical industry. It is known for its ability to undergo nucleophilic substitution reactions, making it a valuable building block in organic synthesis. The presence of the nitro group in its structure contributes to its utility in various applications, including the production of dyes, pigments, pharmaceuticals, and agricultural chemicals. However, due to its potential toxicity and adverse effects on human health, it is crucial to handle this chemical with care.

31604-39-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 31604-39-4 Structure
  • Basic information

    1. Product Name: N-(4-NITROPHENYL)PHTHALIMIDE
    2. Synonyms: TIMTEC-BB SBB007553;N-(P-NITROPHENYL)PHTHALIMIDE;N-(4-NITROPHENYL)PHTHALIMIDE;N-(4-Nitrophenyl)phthalimide, tech. 90%;2-(4-Nitrophenyl)-2H-isoindole-1,3-dione;2-(4-NITRO-PHENYL)-ISOINDOLE-1,3-DIONE
    3. CAS NO:31604-39-4
    4. Molecular Formula: C14H8N2O4
    5. Molecular Weight: 268.22
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 31604-39-4.mol
  • Chemical Properties

    1. Melting Point: 191-192 °C
    2. Boiling Point: 494.2°C at 760 mmHg
    3. Flash Point: 252.7°C
    4. Appearance: /
    5. Density: 1.501g/cm3
    6. Vapor Pressure: 6.56E-10mmHg at 25°C
    7. Refractive Index: 1.694
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. PKA: -4.92±0.20(Predicted)
    11. CAS DataBase Reference: N-(4-NITROPHENYL)PHTHALIMIDE(CAS DataBase Reference)
    12. NIST Chemistry Reference: N-(4-NITROPHENYL)PHTHALIMIDE(31604-39-4)
    13. EPA Substance Registry System: N-(4-NITROPHENYL)PHTHALIMIDE(31604-39-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: S22:Do not inhale dust.; S24/25:Avoid contact with skin and eyes.;
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 31604-39-4(Hazardous Substances Data)

31604-39-4 Usage

Uses

Used in Dye and Pigment Production:
N-(4-Nitrophenyl)phthalimide is used as an intermediate in the production of various dyes and pigments. Its chemical properties allow for the creation of a wide range of colorants used in different industries.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, N-(4-Nitrophenyl)phthalimide is utilized in the synthesis of various drugs. Its reactivity and structural features make it a valuable component in the development of new medicinal compounds.
Used in Agricultural Chemicals:
N-(4-Nitrophenyl)phthalimide also finds application in the synthesis of agricultural chemicals, such as pesticides and herbicides. Its versatility in organic synthesis contributes to the development of effective products for crop protection.
Used in Organic Synthesis:
As a building block in organic synthesis, N-(4-Nitrophenyl)phthalimide is employed in the creation of various organic compounds. Its ability to undergo nucleophilic substitution reactions makes it a useful component in the synthesis of complex organic molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 31604-39-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,0 and 4 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 31604-39:
(7*3)+(6*1)+(5*6)+(4*0)+(3*4)+(2*3)+(1*9)=84
84 % 10 = 4
So 31604-39-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H8N2O4/c17-13-11-3-1-2-4-12(11)14(18)15(13)9-5-7-10(8-6-9)16(19)20/h1-8H

31604-39-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-nitrophenyl)isoindole-1,3-dione

1.2 Other means of identification

Product number -
Other names 1H-Isoindole-1,3(2H)-dione,2-(4-nitrophenyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:31604-39-4 SDS

31604-39-4Relevant articles and documents

π-Stacked hydrogen-bonded dimers in 2-(2-nitrophenylaminocarbonyl)-benzoic acid, and hydrogen-bonded sheets in orthorhombic and monoclinic polymorphs of 2-(4-nitrophenylaminocarbonyl)benzoic acid

Glidewell, Christopher,Low, John N.,Skakle, Janet M.S.,Wardell, James L.

, p. o120-o124 (2004)

Molecules of 2-(2-nitrophenylaminocarbonyl)benzoic acid, C 14H10N2O5, are linked into centrosymmetric R22(8) dimers by a single O-H...O hydrogen bond [H...O = 1.78 A, O...O = 2.623 (2) A and O-H...O = 178°] and these dimers are linked into sheets by a single aromatic π-π stacking interaction. The isomeric compound 2-(4-nitrophenylamino-carbonyl)benzoic acid crystallizes in two polymorphic forms. In the orthorhombic form (space group P21212 1 with Z′ = 1, crystallized from ethanol), the molecules are linked into sheets of R44(22) rings by a combination of one N-H...O hydrogen bond [H...O = 1.96 A, N...O = 2.833 (3) A and N-H...O = 171°] and one O-H...O hydrogen bond [H...O = 1.78 A, O...O = 2.614 (3) A and O-H...O = 173°]. In the monoclinic form (space group P21/n with Z′ = 2, crystallized from acetone), the molecules are linked by a combination of two N-H...O hydrogen bonds [H...O = 2.09 and 2.16 A, N...O = 2.873 (4) and 2.902 (3) A, and N-H...O = 147 and 141°] and two O-H...O hydrogen bonds [H...O = 1.84 and 1.83 A, O...O = 2.664 (3) and 2.666 (3) A, and O-H...O = 166 and 174°] into sheets of some complexity. These sheets are linked into a three-dimensional framework by a single C-H...O hydrogen bond [H...O = 2.45 A, C...O = 3.355 (4) A and C-H...O = 160°].

“On water” nano-Cu2O-catalyzed CO-free one-pot multicomponent cascade cyanation-annulation-aminolysis reaction toward phthalimides

Wen, Xiaowei,Liu, Xiaojuan,Yang, Zhiqi,Xie, Menglan,Liu, Yuxi,Long, Lipeng,Chen, Zhengwang

supporting information, p. 1738 - 1743 (2021/03/14)

An efficient nano-Cu2O-catalyzed cascade multicomponent reaction of 2-halobenzoic acids and trimethylsilyl cyanide with diverse amines was developed using water as a solvent, affording versatileN-substituted phthalimide derivatives in moderate to excellent yields. This novel strategy features carbon monoxide gas-free, environmentally benign, one-pot multistep transformation, commercially available reagents, a cheap catalyst without any additives, wide functional group tolerance, and operational convenience.

Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase

Mahlooji, Iman,Shokri, Maryam,Manoochehri, Rana,Mahboubi-Rabbani, Mohammad,Rezaee, Elham,Tabatabai, Sayyed Abbas

, (2020/06/05)

Soluble epoxide hydrolase (sEH) inhibitors are effective in reducing blood pressure, inflammation, and pain in a number of mammalian disease models. As most classical urea-based sEH inhibitors suffer from poor solubility and pharmacokinetic properties, the development of novel sEH inhibitors with an improved pharmacokinetic specification has received a great deal of attention. In this study, a series of amide-based sEH inhibitors bearing a phthalimide ring as the novel secondary pharmacophore (P2) was designed, synthesized, and evaluated. Docking results illustrated that the amide group as the primary pharmacophore (P1) was placed at a suitable distance from the three key amino acids (Tyr383, Tyr466, and Asp335) for an effective hydrogen bonding. In agreement with these findings, most of the newly synthesized compounds demonstrated moderate?to?high sEH inhibitory activities, relative to 12-(3-adamantan-1-yl-ureido)dodecanoic acid as the reference standard. Compound 12e with a 4-methoxybenzoyl substituent exhibited the highest sEH inhibitory activity, with an IC50 value of 1.06 nM. Moreover, the ADME properties of the compounds were evaluated in silico, and the results revealed appropriate predictions.

Palladium Catalyzed Regioselective Synthesis of Substituted Biaryl Amides through Decarbonylative Arylation of Phthalimides

Samanta, Partha Kumar,Biswas, Papu

, p. 3968 - 3976 (2019/03/26)

The Pd(OAc)2 catalyzed cross-coupling of N-substituted phthalimides with aryl halide provides a single step direct access of a wide range of synthetically appealing ortho-substituted biarylamides in high yields through unique carbonyl (CO) replacement. The reaction proceeds through a ligand-free condition and is well tolerant to the diverse functionality of both imide and halide units. The reaction negates any requirement of organometallic reagent and needs a shorter reaction time and comparatively lower temperature as required for previously reported decarbonylative processes.

Ru-Catalyzed Selective C-H Bond Hydroxylation of Cyclic Imides

Yuan, Yu-Chao,Bruneau, Christian,Dorcet, Vincent,Roisnel, Thierry,Gramage-Doria, Rafael

, p. 1898 - 1907 (2019/02/05)

We report on cyclic imides as weak directing groups for selective monohydroxylation reactions using ruthenium catalysis. Whereas acyclic amides are known to promote the hydroxylation of the C(sp2)-H bond enabling five-membered ring ruthenacycle intermediates, the cyclic imides studied herein enabled the hydroxylation of the C(sp2)-H bond via larger six-membered ruthenacycle intermediates. Furthermore, monohydroxylated products were exclusively obtained (even in the presence of overstoichiometric amounts of reagents), which was rationalized by the difficulty to accommodate coplanar intermediates once the first hydroxyl group was introduced into the substrate. The same reactivity was observed in the presence of palladium catalysts.

The aminocarbonylation of 1,2-diiodoarenes with primary and secondary amines catalyzed by palladium complexes with imidazole ligands

Wójcik, Przemys?aw,Trzeciak, Anna M.

, p. 73 - 83 (2018/05/22)

The efficient carbonylative cyclization of 1,2-diiodobenzene with different primary and secondary amines was performed using a palladium complex with an imidazole ligand, PdCl2(BIM)2, as a catalyst. In reactions performed at 1 atm of CO with primary amines, phthalimides were obtained as the only products with yields of up to 100% in 4 h. An even shorter time, 1 h, was sufficient to obtain the same products employing methyl-2-iodobenzoate as a substrate instead of 1,2-diiodobenzene. In an analogous reaction with secondary amines, 1,2-diiodobenzene was converted to three products, formed in amounts dependent on the reaction conditions. The presence of Pd NPs and soluble palladium intermediates indicated their participation in the catalytic reaction.

L -Proline-Catalyzed Synthesis of Phthalimide Derivatives and Evaluation of Their Antioxidant, Anti-Inflammatory, and Lipoxygenase Inhibition Activities

Perveen, Shagufta,Orfali, Raha

, (2018/08/22)

A study was planned to synthesize the phthalimide derivatives as phthalimides have versatile biological activities. To synthesize the phthalimide derivatives, initially the reaction was optimized with various catalysts, and L-proline was found to be the best catalyst as it provided excellent yield. A series of phthalimide derivatives was synthesized by facile one-top reaction of phthalic acid with aryl amines under mild reaction conditions in the presence of L-proline as catalyst. Products were obtained in excellent yields and structurally characterized by 1H, 13C NMR, and mass spectral data. Products 1-7 were evaluated for antioxidant, anti-inflammatory, and lipoxygenase enzyme inhibition activities. Compounds 1 and 4 showed potent antioxidant activity under DPPH with IC50 values 27.3 and 25.0 μM when compared with the standard BHA (IC50 = 44.2 μM), respectively. Compounds 1 and 4 further showed strong lipoxygenase inhibition activity with IC50 values 21.34 and 20.45 μM when compared with standard baicalein (IC50 = 22.60 μM), respectively. Compound 2 was found to be promising and about equal to the used standard aspirin in the inhibition of bovine serum albumin denaturation, while other compounds showed weak-to-moderate % inhibition.

Imide arylation with aryl(TMP)iodonium tosylates

Basu, Souradeep,Sandtorv, Alexander H.,Stuart, David R.

supporting information, p. 1034 - 1038 (2020/05/06)

Herein, we describe the synthesis of N-aryl phthalimides by metal-free coupling of potassium phthalimide with unsymmetrical aryl(TMP)iodonium tosylate salts. The aryl transfer from the iodonium moiety occurs under electronic control with the electron-rich trimethoxyphenyl group acting as a competent dummy ligand. The yields of N-aryl phthalimides are moderate to high and the coupling reaction is compatible with electron-deficient and sterically encumbered aryl groups.

Unmasking Amides: Ruthenium-Catalyzed Protodecarbonylation of N-Substituted Phthalimide Derivatives

Yuan, Yu-Chao,Kamaraj, Raghu,Bruneau, Christian,Labasque, Thierry,Roisnel, Thierry,Gramage-Doria, Rafael

supporting information, p. 6404 - 6407 (2017/12/08)

The unprecedented transformation of a wide range of synthetically appealing phthalimides into amides in a single-step operation has been achieved in high yields and short reaction times using a ruthenium catalyst. Mechanistic studies revealed a unique, homogeneous pathway involving five-membered ring opening and CO2 release with water being the source of protons.

Thalidomide analogues: Tumor necrosis factor-alpha inhibitors and their evaluation as anti-inflammatory agents

Casal, Juan José,Bollini, Mariela,Lombardo, María Elisa,Bruno, Ana María

, p. 114 - 119 (2016/01/09)

A series of related thalidomide derivatives (2-9) were synthesized by microwave irradiation and evaluated for anti-inflammatory activity. Such activity was assessed in vivo and ex vivo. Compounds 2, 8 and 9 showed the highest levels of inhibition of TNF-α production. On rat paw edema and hyperalgesia assays, compound 9, (1,4-phthalazinedione) demonstrated the highest in vivo anti-inflammatory activity. Thus, compound 9 can be considered as a promising compound to be subjected to further modification to obtain new agents for the treatment of inflammatory diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 31604-39-4